Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Biparametric versus multiparametric MRI for the detection of clinically significant prostate cancer in a diverse, multiethnic population

    There is not yet satisfactory performance data comparing multiparametric MRI (mpMRI) versus biparametric MRI (bpMRI) for detecting prostate cancer (PCa), particularly in high-risk populations. We compared both...

    Max Abramson, Matthew DeMasi, Denzel Zhu, Laena Hines, Wilson Lin in Abdominal Radiology (2024)

  2. No Access

    Article

    Utility of pelvic CT in patients undergoing surveillance for hepatocellular carcinoma: A retrospective multi-institutional study

    To determine the frequency, characteristics and clinical significance of incidental pelvic findings reported on abdominopelvic CT performed for hepatocellular carcinoma (HCC) surveillance in at-risk patients.

    Haneyeh Shahbazian, Kanmani Raja, Claude Sirlin, Gabe Nemzow in Abdominal Radiology (2024)

  3. Article

    Open Access

    Imaging features of intra-abdominal and intra-pelvic causes of hirsutism

    Hirsutism is a relatively common disorder which affects approximately 5% to 15% of women. It is defined by excessive growth of terminal hair in women, which primarily affects areas dependent on androgens, such...

    Arleen Li, Noah Bloomgarden, Shari Friedman, Milana Flusberg in Abdominal Radiology (2024)

  4. No Access

    Article

    Performance of LI-RADS category 5 vs combined categories 4 and 5: a systemic review and meta-analysis

    Computed tomography (CT)/magnetic resonance imaging (MRI) Liver Imaging Reporting and Data System (LI-RADS, LR) category 5 has high specificity and modest sensitivity for diagnosis of hepatocellular carcinoma ...

    Sunyoung Lee, Yeun-Yoon Kim, Jaeseung Shin, Hyejung Shin in European Radiology (2024)

  5. Article

    Open Access

    Prognostic MRI features to predict postresection survivals for very early to intermediate stage hepatocellular carcinoma

    Contrast-enhanced MRI can provide individualized prognostic information for hepatocellular carcinoma (HCC). We aimed to investigate the value of MRI features to predict early (≤ 2 years)/late (> 2 years) recur...

    Hanyu Jiang, Yun Qin, Hong Wei, Tianying Zheng, Ting Yang, Yuanan Wu in European Radiology (2024)

  6. Article

    Open Access

    Ethiodized oil as an imaging biomarker after conventional transarterial chemoembolization

    Conventional transarterial chemoembolization (cTACE) utilizing ethiodized oil as a chemotherapy carrier has become a standard treatment for intermediate-stage hepatocellular carcinoma (HCC) and has been adopte...

    Mishal Mendiratta-Lala, Anum Aslam, Harrison X. Bai, Julius Chapiro in European Radiology (2024)

  7. No Access

    Article

    MRI imaging features for predicting macrotrabecular-massive subtype hepatocellular carcinoma: a systematic review and meta-analysis

    To identify significant MRI features associated with macrotrabecular-massive hepatocellular carcinoma (MTM-HCC), and to assess the distribution of Liver Imaging Radiology and Data System (LI-RADS, LR) category...

    Tae-Hyung Kim, Sungmin Woo, Dong Ho Lee, Richard K. Do in European Radiology (2024)

  8. No Access

    Article

    Liver Imaging Reporting and Data System version 2018 category 5 for diagnosing hepatocellular carcinoma: an updated meta-analysis

    We performed an updated meta-analysis to determine the diagnostic performance of Liver Imaging Reporting and Data System (LI-RADS, LR) 5 category for hepatocellular carcinoma (HCC) using LI-RADS version 2018 (...

    Sunyoung Lee, Yeun-Yoon Kim, Jaeseung Shin, Yun Ho Roh in European Radiology (2024)

  9. Article

    Open Access

    Are dilution, slow injection and care bolus technique the causal solution to mitigating arterial-phase artifacts on gadoxetic acid–enhanced MRI? A large-cohort study

    Arterial-phase artifacts are gadoxetic acid (GA)–enhanced MRI’s major drawback, ranging from 5 to 39%. We evaluate the effect of dilution and slow injection of GA using automated fluoroscopic triggering on liv...

    Sarah Poetter-Lang, Raphael Ambros, Alina Messner, Antonia Kristic in European Radiology (2024)

  10. No Access

    Article

    Prevalence of different LI-RADS v2018 categories in high-risk patients undergoing CT- or MRI-based screening for hepatocellular carcinoma

    To estimate the prevalence of Liver Imaging Reporting and Data System (LI-RADS, LR) v2018 categories reported on CT or MRI performed for hepatocellular carcinoma (HCC) screening.

    Haneyeh Shahbazian, Jason Birnbaum, Patricia J. Burns in Abdominal Radiology (2023)

  11. No Access

    Article

    Optional MRI sequences for LI-RADS: why, what, and how?

    Hepatocellular carcinoma (HCC) is the most common primary malignant tumor of the liver worldwide. Noninvasive diagnosis of HCC is possible based on imaging features, without the need for tissue diagnosis. Live...

    Omar Kamal, Ethan Sy, Victoria Chernyak, Ayushi Gupta, Vahid Yaghmai in Abdominal Radiology (2023)

  12. Article

    Introduction to the special section on quantitative imaging

    Victoria Chernyak, Kathryn J. Fowler in Abdominal Radiology (2022)

  13. No Access

    Article

    Liver imaging: it is time to adopt standardized terminology

    Liver imaging plays a vital role in the management of patients at risk for hepatocellular carcinoma (HCC); however, progress in the field is challenged by nonuniform and inconsistent terminology in the publish...

    Victoria Chernyak, An Tang, Richard K. G. Do, Aya Kamaya, Yuko Kono in European Radiology (2022)

  14. No Access

    Article

    Incidence of pancreatic cancer during long-term follow-up in patients with incidental pancreatic cysts smaller than 2 cm

    To assess the long-term malignancy risk of incidental small pancreatic cysts.

    Masoud Nakhaei, Mathew Bligh, Victoria Chernyak in European Radiology (2022)

  15. No Access

    Article

    What proportion of LI-RADS 5 observations reported in clinical practice do not meet LI-RADS 5 criteria?

    Liver Imaging Reporting and Data System (LI-RADS, LR) category 5 (definite hepatocellular carcinoma [HCC]) is assigned based on combinations of major imaging features (MFs): size, arterial-phase hyperenhanceme...

    Maryam Ghadimi, Jason Birnbaum, Ihab R. Kamel, Claude B. Sirlin in European Radiology (2022)

  16. No Access

    Reference Work Entry In depth

    Imaging of Pelvic Emergencies

    Various nontraumatic emergent conditions occur in the pelvis. As with acute conditions in other organs, timely and accurate diagnosis helps to ensure prompt and optimized treatment and contributes to optimal c...

    Victoria Chernyak in Atlas of Emergency Imaging from Head-to-Toe (2022)

  17. No Access

    Reference Work Entry In depth

    Non-traumatic Emergent Genitourinary Conditions

    Nontraumatic emergent genitourinary conditions require timely diagnosis to ensure timely treatment and an improved clinical outcome. This chapter summarizes the multimodality imaging findings in nontraumatic e...

    Victoria Chernyak in Atlas of Emergency Imaging from Head-to-Toe (2022)

  18. No Access

    Article

    Consensus definitions and interpretation templates for magnetic resonance imaging of Defecatory pelvic floor disorders

    Brooke H. Gurland, Gaurav Khatri, Roopa Ram in International Urogynecology Journal (2021)

  19. No Access

    Article

    Imaging of treatment response during systemic therapy for hepatocellular carcinoma

    Systemic therapy for the treatment of hepatocellular carcinoma (HCC) has rapidly evolved over the last 4 years; eight new drug regimens have gained Food and Drug Administration approval for treatment of advanc...

    William R. Masch, Rony Kampalath, Neehar Parikh in Abdominal Radiology (2021)

  20. No Access

    Article

    Assessing locoregional treatment response to Hepatocellular Carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agents

    Cross-sectional imaging with contrast-enhanced magnetic resonance imaging (MRI) is routinely performed in patients with hepatocellular carcinoma (HCC) to assess tumor response to locoregional therapy (LRT). Cu...

    Anum Aslam, Amita Kamath, Bradley Spieler, Mark Maschiocchi in Abdominal Radiology (2021)

previous disabled Page of 3